Complications of portal hypertension, including ascites, gastrointestinal bleeding, hepatic
hydrothorax, and hepatic encephalopathy, are associated with significant morbidity and …

More than five decades after it was originally conceptualized as rescue therapy for patients
with intractable variceal bleeding, the transjugular intrahepatic portosystemic shunt (TIPS) …

These guidelines on transjugular intrahepatic portosystemic stent-shunt (TIPSS) in the
management of portal hypertension have been commissioned by the Clinical Services and …

Background & Aims Compared with drugs plus endoscopy, placement of transjugular
portosystemic shunt within 72 hours of admission to the hospital (early or preventive …

This is a comprehensive guidance on the use of interventional radiology endovascular
techniques in the management of variceal hemorrhage from the American Association for …

In this review, we summarise the current knowledge on the indications and contraindications
of transjugular intrahepatic portosystemic shunt (TIPS) placement for the treatment of the …

In selected patients with cirrhosis and ascites, transjugular intrahepatic portosystemic shunt
(TIPS) placement improves control of ascites and may reduce mortality. In this review, we …

Transjugular intrahepatic portosystemic shunt (TIPS) is increasingly used worldwide to treat
the complications of portal hypertension in patients with advanced cirrhosis. However, its …

Conclusions: After TIPS implantation, mortality is increased by aging, but TIPS placement
should not be precluded in patients older than 70 years. In older adults, creatinine and …

Abstract Background and Aims Recently published criteria by 2019 Cirrhotic
Cardiomyopathy Consortium set a lower threshold for reduced ejection fraction to diagnose …